{"id":13090,"date":"2018-05-02T21:18:56","date_gmt":"2018-05-02T20:18:56","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=13090"},"modified":"2018-05-02T21:18:56","modified_gmt":"2018-05-02T20:18:56","slug":"sesion-bibliografica-the-lancet-infectious-diseases-2","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/sesiones-bibliograficas\/2018-05-02\/sesion-bibliografica-the-lancet-infectious-diseases-2\/","title":{"rendered":"Sesi\u00f3n bibliogr\u00e1fica: The Lancet Infectious Diseases."},"content":{"rendered":"<p><a href=\"https:\/\/mileon.wordpress.com\/2017\/10\/07\/sesion-bibliografica-the-lancet-infectious-diseases\/lancet-id-306x186\/#main\" rel=\"attachment wp-att-12588\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-12588 alignright\" src=\"https:\/\/mileon.files.wordpress.com\/2017\/10\/lancet-id-306x186.png?w=300\" alt=\"\" width=\"202\" height=\"126\" \/><\/a>El 27 de abril de 2018 el Dr Jose Luis Mostaza Fern\u00e1ndez (Jefe Servicio MI) analiz\u00f3 varios art\u00edculos del Lancet ID, son:<\/p>\n<ul>\n<li><em>Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.<\/em><\/li>\n<li><em>Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram negative bacteria: an open label, randomised controlled trial. Trial AIDA.<\/em><\/li>\n<li><em>High dose tigecycline for the treatment of nosocomial carbapenem resistant Klebsiella pneumoniae bloodstream infections. A retrospective cohort study.<\/em><\/li>\n<li><em>The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster randomised crossover trial.<\/em><\/li>\n<li><em>Discovery, research and development of new antibiotics: the WHO priority list of antibiotic resistant bacteria and tuberculosis.<\/em><\/li>\n<li><em>Extended pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open label, phase 3b\/4 trial.<\/em><\/li>\n<\/ul>\n<p>Su presentaci\u00f3n se puede descargar <strong><a href=\"https:\/\/drive.google.com\/file\/d\/1ZDJSx7TASJBdgOYmjhUQ8I5dbq13h7C7\/view?usp=sharing\">aqu\u00ed.<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El 27 de abril de 2018 el Dr Jose Luis Mostaza Fern\u00e1ndez (Jefe Servicio MI) analiz\u00f3 varios art\u00edculos del Lancet ID, son: Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram negative [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[722],"tags":[],"class_list":["post-13090","post","type-post","status-publish","format-standard","hentry","category-sesiones-bibliograficas"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=13090"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13090\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=13090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=13090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=13090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}